Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Prostate Adenocarcinoma × bicalutamide × Clear all

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 111 Breast Neoplasms 10 Neoplasm Metastasis 6 Neoplasms 5 Triple Negative Breast Neoplasms 4 Bulbo-Spinal Atrophy, X-Linked 4 Salivary Gland Neoplasms 2 Osteoporosis 2 Lower Urinary Tract Symptoms 2 Hirsutism 2 Thrombocytosis 1 Stage I Prostate Adenocarcinoma AJCC v7 1 Stage I Prostate Adenocarcinoma 1 Sexual Dysfunction, Physiological 1 Recurrence 1 Prostate Adenocarcinoma 1 Primary Myelofibrosis 1 Primary Dysautonomias 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Polycystic Ovary Syndrome 1 Pancreatic Neoplasms 1 Paget Disease, Extramammary 1 PSA Level Greater Than Two 1 Ovarian Neoplasms 1 Non-Muscle Invasive Bladder Neoplasms 1 Non Castrate Metastatic Prostate Cancer 1 Myeloproliferative Disorders 1 Myelodysplastic-Myeloproliferative Diseases 1 Myelodysplastic Syndromes 1 Multiple Myeloma 1

Interventions

Radiosurgery 4 Magnetic Resonance Spectroscopy 4 luprolide acetate gel depot 3 enzalutamide 3 Specimen Handling 2 Radiotherapy 2 Radiation 2 Leuprolide 2 Goserelin 2 Biopsy 2 relugolix 1 radium Ra 223 dichloride 1 niraparib 1 gallium 68 PSMA-11 1 fluciclovine F-18 1 entinostat 1 bicalutamide 1 atezolizumab 1 apalutamide 1 acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 1 abiraterone 1 X-Rays 1 Triptorelin Pamoate 1 Receptors, Bombesin 1 Radiotherapy, Image-Guided 1 Radiation Dose Hypofractionation 1 Proton Therapy 1 Prednisone 1 PROSTVAC 1 Neoadjuvant Therapy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04943536 2026-02-27

BiolenRT

Alessa Therapeutics Inc.

Phase 1 Active not recruiting

Prostate Adenocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡